Tuberculosis Drug Resistance in an Area of Low Endemicity in 2004 to 2006: Semiquantitative Drug Susceptibility Testing and Genotyping
- 1 December 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 46 (12) , 4064-4067
- https://doi.org/10.1128/jcm.01114-08
Abstract
We determined the quantitative levels and the genetic mechanisms of resistance in drug-resistant clinical isolates of Mycobacterium tuberculosis sampled over a period of 3 years ( n = 45; 17 of the isolate were multidrug resistant). Our results led us to hypothesize that some strains categorized as resistant to isoniazid, ethambutol, or streptomycin by standard laboratory procedures of in vitro drug susceptibility testing may still respond to a treatment regimen that includes these agents.This publication has 22 references indexed in Scilit:
- Genotype MTBDR plus : a Further Step toward Rapid Identification of Drug-Resistant Mycobacterium tuberculosisJournal of Clinical Microbiology, 2008
- Tuberculosis: drug resistance, fitness, and strategies for global controlEuropean Journal of Pediatrics, 2007
- Evaluation of the GenoType MTBDRplus Assay for Rifampin and Isoniazid Susceptibility Testing of Mycobacterium tuberculosis Strains and Clinical SpecimensJournal of Clinical Microbiology, 2007
- Drug-susceptibility testing in tuberculosis: methods and reliability of resultsEuropean Respiratory Journal, 2005
- Isoniazid Pharmacokinetics-Pharmacodynamics in an Aerosol Infection Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2004
- Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Mycobacterial InfectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric MethodsJournal of Clinical Microbiology, 2002
- Drug-resistant tuberculosisThe Lancet, 2001
- A Single 16S Ribosomal RNA Substitution Is Responsible for Resistance to Amikacin and Other 2‐Deoxystreptamine Aminoglycosides inMycobacterium abscessusandMycobacterium chelonaeThe Journal of Infectious Diseases, 1998
- Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknotMolecular Microbiology, 1993